Researchers have developed a new diagnostic technique to accurately differentiate bladder cancer from benign inflammation using AHNAK2 protein biomarkers.
A novel protein has been discovered that could be a useful blood-based biomarker to monitor the progression of inherited Alzheimer’s disease, over a decade before the clinical symptoms appear.
Researchers from Queen’s University Belfast (UK) have developed a new enzyme biomarker test that has the potential to detect disease and infection.
A new molecular engineering method, termed TAC-seq, has been developed to enhance the precision of clinical biomarker analysis.
Find out more about the current research focuses at KCAS Bioanalytical & Biomarker Services and how the industry has evolved over the last 5–10 years in this interview with John Bucksath (KCAS).
Find out more about the latest news in cardiovascular research including the development of disease biomarkers and cardiomyocyte sensors in this round-up.
Researchers from McMaster University (Ontario, Canada) have discovered several new biomarkers that could allow earlier detection of cystic fibrosis from a single drop of blood.
A noninvasive skin-stripping test has been developed to differentiate between eczema and psoriasis when diagnosing inflammatory skin diseases.
Researchers from the University of Queensland (Australia) have discovered a unique biomarker common to multiple cancers that has the potential to change the way early stage cancer is diagnosed.
Researchers at the CEU Cardenal Herrera University (Valencia, Spain) have discovered the three most efficient types of salivary biomarkers for the early detection of oral cancer.